StockData
Eupraxia Pharmaceuticals Inc. logo

Eupraxia Pharmaceuticals Inc. (EPRX) stock

EPRXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 40-F on Mar 13, 2026Score 5/30
$6.21−0.41 (-6.19%)

Close on Nov 18, 2026Market cap $374.43MP/E –Yield –

Eupraxia Pharmaceuticals revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

For fiscal 2025 it was $0.

Annual revenue

PeriodPeriod endValueChange
FY2025Dec 31, 2025$0–
FY2024Dec 31, 2024$0–
FY2023Dec 31, 2023$0–

More Eupraxia Pharmaceuticals figures

See a number that looks wrong?